1. Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2022) Authors: Welker, James; Pulido, Juan D; Catanzaro, Andrew T; Malvestutto, Carlos D; Li, Zihai; Cohen, Jonathan B; Whitman, Eric D; Byrne, Dana; Giddings, Olivia K; Lake, Jordan E; Chua, Joel V; Li, Ella; Chen, Jian; Zhou, Xiang; He, Kun; Gates, Davis; Kaur, Amarjot; Chen, Jamie; Chou, Hung-Yen; Devenport,... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗